HCPCS Level II · retired code
J7513 — Daclizumab, parenteral, 25 mg
J7513 was retired on Dec 31, 2025
CMS ended J7513 after Dec 31, 2025. Don’t report it for later dates of service. Look up the drug for its current code.
Code
CMS HCPCS fileHCPCS codeJ7513
Billing unit25 mg
- Descriptor
- Daclizumab, parenteral, 25 mg
- Short descriptor
- Daclizumab, parenteral
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2026
The billing unit is read from the descriptor. Confirm it against the CMS file before billing.
Find the NDC
Med-Code hasn’t mapped J7513 to specific products yet. Search the FDA NDC Directory for the drug named in the descriptor, and check the route and strength match the code.
J7513: common questions
- Is J7513 a CPT code?
- No. J7513 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What is one billing unit of J7513?
- One unit of J7513 is 25 mg, as stated in the code's descriptor. Units to report = dose given ÷ 25 mg. J-code billing units.